ArticleBreast cancer research : BCR2023

Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.

Christine Lundgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.